Journal of International Oncology ›› 2021, Vol. 48 ›› Issue (5): 292-295.doi: 10.3760/cma.j.cn371439-20200629-00056
• Reviews • Previous Articles Next Articles
Luo Lan, Chen Chuang, Li Xinqian, Sun Shengrong()
Received:
2020-06-29
Revised:
2020-11-08
Online:
2021-05-08
Published:
2021-06-09
Contact:
Sun Shengrong
E-mail:sun137@sina.com
Luo Lan, Chen Chuang, Li Xinqian, Sun Shengrong. Relationship between bacteria and breast cancer[J]. Journal of International Oncology, 2021, 48(5): 292-295.
[1] |
Parida S, Sharma D. The power of small changes: comprehensive analyses of microbial dysbiosis in breast cancer[J]. Biochim Biophys Acta Rev Cancer, 2019,1871(2):392-405. DOI: 10.1016/j.bbcan.2019.04.001.
doi: 10.1016/j.bbcan.2019.04.001 |
[2] |
Bhatt AP, Redinbo MR, Bultman SJ. The role of the microbiome in cancer development and therapy[J]. CA Cancer J Clin, 2017,67(4):326-344. DOI: 10.3322/caac.21398.
doi: 10.3322/caac.v67.4 |
[3] |
Tsilimigras MC, Fodor A, Jobin C. Carcinogenesis and therapeutics: the microbiota perspective[J]. Nat Microbiol, 2017,2:17008. DOI: 10.1038/nmicrobiol.2017.8.
doi: 10.1038/nmicrobiol.2017.8 pmid: 28225000 |
[4] | 纪周新, 贺德. 微生物群与胰腺癌[J]. 国际肿瘤学杂志, 2020,47(1):46-50. DOI: 10.3760/cma.j.issn.1673-422X.2020.01.009. |
[5] |
Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and cancer: friends or faux?[J]. Int J Mol Sci, 2020,21(9):3115. DOI: 10.3390/ijms21093115.
doi: 10.3390/ijms21093115 |
[6] |
Stewart OA, Wu F, Chen Y. The role of gastric microbiota in gastric cancer[J]. Gut Microbes, 2020,11(5):1220-1230. DOI: 10.1080/19490976.2020.1762520.
doi: 10.1080/19490976.2020.1762520 pmid: 32449430 |
[7] |
Urbaniak C, Cummins J, Brackstone M, et al. Microbiota of human breast tissue[J]. Appl Environ Microbiol, 2014,80(10):3007-3014. DOI: 10.1128/AEM.00242-14.
doi: 10.1128/AEM.00242-14 |
[8] |
Urbaniak C, Gloor GB, Brackstone M, et al. The microbiota of breast tissue and its association with breast cancer[J]. Appl Environ Microbiol, 2016,82(16):5039-5048. DOI: 10.1128/AEM.01235-16.
doi: 10.1128/AEM.01235-16 |
[9] |
Hieken TJ, Chen J, Hoskin TL, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease[J]. Sci Rep, 2016,6:30751. DOI: 10.1038/srep30751.
doi: 10.1038/srep30751 |
[10] | Kim M, Vogtmann E, Ahlquist DA, et al. Fecal metabolomic signatures in colorectal adenoma patients are associated with gut micro-biota and early events of colorectal cancer pathogenesis[J]. mBio, 2020,11(1):e03186-19. DOI: 10.1128/mBio.03186-19. |
[11] |
Markowski MC, Boorjian SA, Burton JP, et al. The microbiome and genitourinary cancer: a collaborative review[J]. Eur Urol, 2019,75(4):637-646. DOI: 10.1016/j.eururo.2018.12.043.
doi: 10.1016/j.eururo.2018.12.043 |
[12] |
Urbaniak C, Burton JP, Reid G. Breast, milk and microbes: a complex relationship that does not end with lactation[J]. Womens Health (Lond), 2012,8(4):385-398. DOI: 10.2217/whe.12.23.
doi: 10.2217/whe.12.23 pmid: 22757730 |
[13] |
Xuan C, Shamonki JM, Chung A, et al. Microbial dysbiosis is associated with human breast cancer[J]. PLoS One, 2014,9(1):e83744. DOI: 10.1371/journal.pone.0083744.
doi: 10.1371/journal.pone.0083744 |
[14] |
Pleguezuelos-Manzano C, Puschhof J, Huber A, et al. Mutational signature in colorectal cancer caused by genotoxic pks+E. coli[J]. Nature, 2020,580(7802):269-273. DOI: 10.1038/s41586-020-2080-8.
doi: 10.1038/s41586-020-2080-8 pmid: 32106218 |
[15] |
Banerjee S, Wei Z, Tan F, et al. Distinct microbiological signatures associated with triple negative breast cancer[J]. Sci Rep, 2015,5:15162. DOI: 10.1038/srep15162.
doi: 10.1038/srep15162 |
[16] |
Wang H, Altemus J, Niazi F, et al. Breast tissue, oral and urinary microbiomes in breast cancer[J]. Oncotarget, 2017,8(50):88122-88138. DOI: 10.18632/oncotarget.21490.
doi: 10.18632/oncotarget.v8i50 |
[17] |
Smith A, Pierre JF, Makowski L, et al. Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic Black and non-Hispanic White women[J]. Sci Rep, 2019,9(1):11940. DOI: 10.1038/s41598-019-48348-1.
doi: 10.1038/s41598-019-48348-1 |
[18] |
Chiba A, Bawaneh A, Velazquez C, et al. Neoadjuvant chemo-therapy shifts breast tumor microbiota populations to regulate drug responsiveness and the development of metastasis[J]. Mol Cancer Res, 2020,18(1):130-139. DOI: 10.1158/1541-7786.MCR-19-0451.
doi: 10.1158/1541-7786.MCR-19-0451 |
[19] |
Meng S, Chen B, Yang J, et al. Study of microbiomes in aseptically collected samples of human breast tissue using needle biopsy and the potential role of in situ tissue microbiomes for promoting malignancy[J]. Front Oncol, 2018,8:318. DOI: 10.3389/fonc.2018.00318.
doi: 10.3389/fonc.2018.00318 |
[20] |
Chan AA, Bashir M, Rivas MN, et al. Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors[J]. Sci Rep, 2016,6:28061. DOI: 10.1038/srep28061.
doi: 10.1038/srep28061 |
[21] |
Yazdi HR, Movafagh A, Fallah F, et al. Evaluation of methylobacterium radiotolerance and sphyngomonas yanoikoaie in sentinel lymph nodes of breast cancer cases[J]. Asian Pac J Cancer Prev, 2016,17(S3):279-285. DOI: 10.7314/apjcp.2016.17.s3.279.
doi: 10.7314/APJCP.2016.17.S3.279 |
[22] |
Guglielmi G. How gut microbes are joining the fight against cancer[J]. Nature, 2018,557(7706):482-484. DOI: 10.1038/d41586-018-05208-8.
doi: 10.1038/d41586-018-05208-8 pmid: 29795257 |
[23] | Shi J, Geng C, Sang M, et al. Effect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer[J]. Oncol Lett, 2019,17(6):5050-5056. DOI: 10.3892/ol.2019.10187. |
[24] |
Guinter MA, McLain AC, Merchant AT, et al. A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women[J]. Int J Cancer, 2018,143(3):580-590. DOI: 10.1002/ijc.31387.
doi: 10.1002/ijc.31387 pmid: 29574860 |
[25] |
Kovács T, Mikó E, Vida A, et al. Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors[J]. Sci Rep, 2019,9(1):1300. DOI: 10.1038/s41598-018-37664-7.
doi: 10.1038/s41598-018-37664-7 |
[26] |
Ingman WV. The gut microbiome: a new player in breast cancer metastasis[J]. Cancer Res, 2019,79(14):3539-3541. DOI: 10.1158/0008-5472.CAN-19-1698.
doi: 10.1158/0008-5472.CAN-19-1698 |
[27] | Sellitto A, D'Agostino Y, Alexandrova E, et al. Insights into the role of estrogen receptor β in triple-negative breast cancer[J]. Can-cers (Basel), 2020,12(6):1477. DOI: 10.3390/cancers-12061477. |
[28] |
Ferreira Almeida C, Oliveira A, João Ramos M, et al. Estrogen receptor-positive (ER+) breast cancer treatment: are multi-target compounds the next promising approach?[J]. Biochem Pharmacol, 2020,177:113989. DOI: 10.1016/j.bcp.2020.113989.
doi: 10.1016/j.bcp.2020.113989 |
[29] |
Fernández MF, Reina-Pérez I, Astorga JM, et al. Breast Cancer and its relationship with the microbiota[J]. Int J Environ Res Public Health, 2018,15(8):1747. DOI: 10.3390/ijerph15081747.
doi: 10.3390/ijerph15081747 |
[30] |
Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review[J]. Expert Rev Gastroenterol Hepatol, 2019,13(1):3-15. DOI: 10.1080/17474124.2019.1543023.
doi: 10.1080/17474124.2019.1543023 pmid: 30791839 |
[31] |
Parida S, Sharma D. The microbiome-estrogen connection and breast cancer risk[J]. Cells, 2019,8(12):1642. DOI: 10.3390/cells8121642.
doi: 10.3390/cells8121642 |
[32] |
Pellegrini M, Ippolito M, Monge T, et al. Gut microbiota composition after diet and probiotics in overweight breast cancer survivors: a randomized open-label pilot intervention trial[J]. Nutrition, 2020,74:110749. DOI: 10.1016/j.nut.2020.110749.
doi: S0899-9007(20)30032-0 pmid: 32234652 |
[33] |
Bess EN, Bisanz JE, Yarza F, et al. Genetic basis for the cooperative bioactivation of plant lignans by Eggerthella lenta and other human gut bacteria[J]. Nat Microbiol, 2020,5(1):56-66. DOI: 10.1038/s41564-019-0596-1.
doi: 10.1038/s41564-019-0596-1 |
[34] |
Lakritz JR, Poutahidis T, Mirabal S, et al. Gut bacteria require neutrophils to promote mammary tumorigenesis[J]. Oncotarget, 2015,6(11):9387-9396. DOI: 10.18632/oncotarget.3328.
doi: 10.18632/oncotarget.v6i11 |
[35] |
Erdman SE, Poutahidis T. Gut bacteria and cancer[J]. Biochim Biophys Acta, 2015,1856(1):86-90. DOI: 10.1016/j.bbcan.2015.05.007.
doi: 10.1016/j.bbcan.2015.05.007 pmid: 26050963 |
[1] | Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[2] | Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[3] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[4] | Sa Qiang, Xu Hangcheng, Wang Jiayu. Advances in immunotherapy for breast cancer [J]. Journal of International Oncology, 2024, 51(4): 227-234. |
[5] | Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong. Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer [J]. Journal of International Oncology, 2024, 51(4): 235-238. |
[6] | Chen Boguang, Wang Sugui, Zhang Yongjie. Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer [J]. Journal of International Oncology, 2024, 51(2): 73-82. |
[7] | Gu Huayan, Zhu Teng, Guo Guilong. Breast microbiota and breast cancer: present and future [J]. Journal of International Oncology, 2024, 51(1): 55-58. |
[8] | Wang Jing, Xu Wenting. Value of NLR, CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm [J]. Journal of International Oncology, 2023, 50(9): 520-526. |
[9] | Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying. Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients [J]. Journal of International Oncology, 2023, 50(9): 527-531. |
[10] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng. Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway [J]. Journal of International Oncology, 2023, 50(8): 449-456. |
[11] | Pan Shulan, Liu Chang, He Ping. Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer [J]. Journal of International Oncology, 2023, 50(8): 457-462. |
[12] | Guo Ciliang, Jiang Chunping, Wu Junhua. Gut microbiome and tumor immunotherapy [J]. Journal of International Oncology, 2023, 50(7): 432-436. |
[13] | Wang Wende, Zeng De. Research progress on the mechanism of endocrine therapy resistance for breast cancer [J]. Journal of International Oncology, 2023, 50(6): 352-356. |
[14] | Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai. Research progress on the application of combining radiotherapy and systemic therapy in breast cancer [J]. Journal of International Oncology, 2023, 50(6): 362-367. |
[15] | Lyu Lu, Sun Pengfei. Gut flora and cervical cancer [J]. Journal of International Oncology, 2023, 50(6): 373-376. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||